SEC Form 5 · accession 0001570523-18-000014
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 3:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Mar 24, 2016 | P | 1,250 | $0.1545 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 750 | $0.1566 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 1,000 | $0.1566 | A | 20,800,359 | D | |
| Common stock | Mar 24, 2016 | P | 1,000 | $0.1561 | A | 20,800,359 | D | |
| Common stock | Mar 28, 2016 | P | 5,000 | $0.1438 | A | 20,800,359 | D | |
| Common stock | Mar 29, 2016 | P | 5,000 | $0.1374 | A | 20,800,359 | D | |
| Common stock | Mar 30, 2016 | P | 5,000 | $0.155 | A | 20,800,359 | D | |
| Common stock | Mar 31, 2016 | P | 1,000 | $0.17 | A | 20,800,359 | D | |
| Common stock | Apr 6, 2016 | P | 1,250 | $0.1496 | A | 20,800,359 | D | |
| Common stock | Apr 6, 2016 | P | 5,000 | $0.152 | A | 20,800,359 | D | |
| Common stock | Apr 6, 2016 | P | 3,750 | $0.152 | A | 20,800,359 | D | |
| Common stock | Apr 6, 2016 | P | 900 | $0.1494 | A | 20,800,359 | D | |
| Common stock | Apr 6, 2016 | P | 5,100 | $0.1505 | A | 20,800,359 | D | |
| Common stock | Apr 6, 2016 | P | 200 | $0.151 | A | 20,800,359 | D | |
| Common stock | Apr 8, 2016 | P | 3,000 | $0.1498 | A | 20,800,359 | D | |
| Common stock | Apr 14, 2016 | P | 500 | $0.1686 | A | 20,800,359 | D | |
| Common stock | Apr 15, 2016 | P | 3,500 | $0.1618 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 1,680 | $0.184 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 500 | $0.1899 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 3,420 | $0.185 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 5,000 | $0.1849 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 100 | $0.1849 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 500 | $0.1899 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 300 | $0.1883 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 500 | $0.1879 | A | 20,800,359 | D | |
| Common stock | Apr 18, 2016 | P | 1,000 | $0.192 | A | 20,800,359 | D | |
| Common stock | Apr 21, 2016 | P | 200 | $0.169 | A | 20,800,359 | D | |
| Common stock | Apr 26, 2016 | P | 200 | $0.17 | A | 20,800,359 | D | |
| Common stock | Apr 27, 2016 | P | 2,000 | $0.1739 | A | 20,800,359 | D | |
| Common stock | May 4, 2016 | P | 1,000 | $0.148 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 10 of 16 submissions.